Back to User profile » Dr Binbin Cong
Papers published by Dr Binbin Cong:
MLN51 (Metastatic Lymph Node Gene 51)/CASC3 (Cancer Susceptibility Candidate Gene 3), A Putative Tumour Suppressor in Breast Cancer, the Clinical and Therapeutic Connections
Cong B, Martin TA, Cao X, Ruge FS, Li AX, Mansel RE, Wang Y, Jiang WG
Breast Cancer: Targets and Therapy 2026, 18:565199
Published Date: 14 January 2026
Molecular and Cellular Machinery of Lymphatic Metastasis in Breast Cancer
Cong B, Cao X, Jiang WG, Ye L
OncoTargets and Therapy 2025, 18:199-209
Published Date: 4 February 2025
Controversial Opinion of “All pCRs are the Same” in St. Gallen International Consensus Guidelines 2021
Cong BB, Wang YS
Cancer Management and Research 2022, 14:1019-1021
Published Date: 6 March 2022
Axillary management still needed for patients with sentinel node micrometastases
Cong BB, Yu JM, Wang YS
Cancer Management and Research 2019, 11:2097-2100
Published Date: 8 March 2019
Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
Cao XS, Cong BB, Sun X, Qiu PF, Wang YS
OncoTargets and Therapy 2015, 8:2873-2874
Published Date: 9 October 2015
Validation study of the modified injection technique for internal mammary sentinel lymph node biopsy in breast cancer
Cong BB, Cao XS, Qiu PF, Liu YB, Zhao T, Chen P, Wang CJ, Zhang ZP, Sun X, Wang YS
OncoTargets and Therapy 2015, 8:2705-2708
Published Date: 24 September 2015
Axillary and internal mammary sentinel lymph node biopsy in male breast cancer patients: case series and review
Cao X, Wang C, Liu Y, Qiu P, Cong B, Wang Y
OncoTargets and Therapy 2015, 8:1499-1502
Published Date: 17 June 2015